Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Case Report

Pegylated Liposomal Doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo

Cite this Article

To cite this article please use the text below.

Yuan Y, Orlow SJ, Curtin J, Downey A and Muggia F (2008) Pegylated Liposomal Doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo ecancer 2 111



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation